Clinical Genomics Adoption Will Broaden Precision Medicine Markets

Shared on01 May 25
Fair value Increased 4.85%

Shared on24 Apr 25
Fair value Decreased 7.98%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Increased 3.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 10%

Shared on02 Apr 25
Fair value Decreased 1.72%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.